VYNE THERAPEUTICS INC. (YARW) Capital expenditures 2016–2025
VYNE THERAPEUTICS INC. (YARW) annual capital expenditure history — cash spent on property, plant and equipment, per SEC filings.
$0FY2025 · since FY2016: $31,000 → $0
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $0 | -100.0% |
| FY2024 | $117,000 | — |
| FY2023 | $0 | — |
| FY2021 | $0 | -100.0% |
| FY2020 | $113,000 | -89.3% |
| FY2019 | $1.1M | +86.6% |
| FY2018 | $567,000 | +2000.0% |
| FY2017 | $27,000 | -12.9% |
| FY2016 | $31,000 | — |
Capital expenditures are shown as the positive cash amount spent, as reported on the cash-flow statement.
Source: SEC XBRL filings · For reference only · Not investment advice